Growth of Tumor-Derived Activated T Cells for the Treatment of Advanced Cancer-Reference-Cited by-同舟云学术

Growth of Tumor-Derived Activated T Cells for the Treatment of Advanced Cancer

Published:2000-08 Issue:4 Volume:15 Page:357-366
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Lewko Walter M.,Hall Peggy B.,Oldham Robert K.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2000.15.357

Reference26 articles.

1. Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

2. TUMOUR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN TREATMENT OF ADVANCED CANCER

3. Inpatient continuous-infusion interleukin-2 in 788 patients with cancer the national biotherapy study group experience

4. Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial

5. Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a National Biotherapy Study Group trial.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy;Journal of Biological Engineering;2021-04-13

2. Cancer Immunotherapy;Cancer Biotherapy and Radiopharmaceuticals;2011-02

3. Biological therapy of melanoma;Principles of Cancer Biotherapy;2009

4. Cytokines;Principles of Cancer Biotherapy;2009

5. Cancer biotherapy: general principles;Principles of Cancer Biotherapy;2009